Description
While the risk differences between genotypes are established, the threshold editing efficiency needed for clinical benefit remains unknown. This dosage-response relationship is essential for determining therapeutic feasibility and success criteria.
Gap type: open_question Source paper: Prime Editing of Alzheimer’s Disease High-Risk APOE4 Allele by Brain-Directed Adeno-Associated Virus Vectors. (2026, Hum Gene Ther, PMID:41449667)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:41.871251+00:00”, “resolution_summary”: “Resolved by hypothesis h-42f50a4a: Prime Editing Precision Correction of APOE4 to APOE3 in Microglia. Supporting evidence includes debate sess_SDA-2026-04-07-gap-pubmed-20260406-062202-c8c5a9a1_task_9aae8fc5.”, “match_counts”: {“hypothesis_matches”: 3, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-42f50a4a”, “title”: “Prime Editing Precision Correction of APOE4 to APOE3 in Microglia”, “score”: 0.255, “reason”: “24 token overlaps; entity overlap: apoe4”, “analysis_id”: “SDA-2026-04-03-gap-crispr-neurodegeneration-20260402”, “target_gene”: “APOE”, “target_pathway”: “APOE-mediated cholesterol/lipid transport”, “disease”: “neurodegeneration”, “composite_score”: 0.826767, “confidence_score”: 0.7, “status”: “promoted”, “pubmed_evidence_ids”: [“39642875”, “40639927”, “41276911”, “41288387”, “41338186”]}, {“id”: “h-bc8867b7ad”, “title”: “APOE4 astrocytes exhibit impaired cholesterol efflux via ABCA1/ABCG1 transporters, driving intracellular lipid droplet accumulation and secondary neuronal cholesterol deficiency”, “score”: 0.231, “reason”: “22 token overlaps; entity overlap: apoe4”, “analysis_id”: “SDA-2026-04-04-gap-apoe4-lipid-metabolism”, “target_gene”: “ABCA1, ABCG1”, “target_pathway”: null, “disease”: “neuroscience”, “composite_score”: 0.757724, “confidence_score”: 0.33, “status”: “proposed”, “pubmed_evidence_ids”: [“26878670”, “30833792”, “31988060”, “35899587”, “37995685”]}, {“id”: “h-44195347”, “title”: “APOE4 Allosteric Rescue via Small Molecule Chaperones”, “score”: 0.221, “reason”: “23 token overlaps; entity overlap: apoe4”, “analysis_id”: “sda-2026-04-01-gap-010”, “target_gene”: “APOE”, “target_pathway”: “Apolipoprotein E lipid transport”, “disease”: “neurodegeneration”, “composite_score”: 0.764904, “confidence_score”: 0.4, “status”: “debated”, “pubmed_evidence_ids”: [“27097127”, “27365453”, “30335591”, “31367008”, “33891876”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062202-c8c5a9a1_task_9aae8fc5”, “title”: “The abstract identifies APOE4 association with increased TDP-43 pathology but the mechanistic link is unexplained. This connection could reveal novel therapeutic targets since APOE4 is the strongest genetic risk factor for AD.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Pathology in Alzheimer’s Disease. (2021, Mol Neurodegener, PMID:34930382)”, “score”: 0.502, “reason”: “9 token overlaps; entity overlap: apoe4, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062202-c8c5a9a1”, “quality_score”: 0.61, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-184126-b2c3e2e8”, “title”: “This study shows APOE4 carriers have enhanced beneficial innate immune responses, directly contradicting the established view of APOE4 as purely detrimental in neurodegeneration. This paradox challenges fundamental assumptions about APOE4’s role in AD pathogenesis.\n\nGap type: contradiction\nSource paper: APOE genotype-specific differences in the innate immune response (2021, JAMA Neurology, PMID:33432245)”, “score”: 0.462, “reason”: “8 token overlaps; entity overlap: apoe4, pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-184126-b2c3e2e8”, “quality_score”: 0.6, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-193244-89904941_20260416-035819”, “title”: “The abstract identifies APOE4’s primary effect on oligodendrocyte cholesterol metabolism but doesn’t explain the mechanistic pathway. Understanding this mechanism is critical for developing targeted therapeutics that address the root cause rather than downstream effects.\n\nGap type: unexplained_observation\nSource paper: APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes (2022, Nature, PMID:34788101)”, “score”: 0.404, “reason”: “6 token overlaps; entity overlap: apoe4, pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-193244-89904941”, “quality_score”: 0.69, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062202-5c32c50a_task_9aae8fc5”, “title”: “AD patients with TDP-43 pathology show worse cognitive impairment, but how TDP-43 mechanistically contributes to this severity is unknown. Understanding this could identify TDP-43 as a therapeutic target for cognitive preservation in AD.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Pathology in Alzheimer’s Disease. (2021, Mol Neurodegener, PMID:34930382)”, “score”: 0.377, “reason”: “8 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062202-5c32c50a”, “quality_score”: 0.734, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-16-gap-pubmed-20260411-082446-2c1c9e2d”, “title”: “The abstract explicitly questions whether AD’s hallmark pathologies induce cholinergic dysfunction or vice versa. This fundamental causality question is critical for determining therapeutic targets but remains unresolved despite evidence that β-amyloid affects cholinergic receptors.\n\nGap type: open_question\nSource paper: The cholinergic system in aging and neuronal degeneration. (2011, Behavioural brain research, PMID:21145918)”, “score”: 0.355, “reason”: “9 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-16-gap-pubmed-20260411-082446-2c1c9e2d”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}